MSC Exosomes for Aging-Related Disorder Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for aging-related disorders are limited in their ability to effectively address the broad range of aging effects across various organs and systems, and there is a need for therapies that can slow aging or treat age-related diseases beyond skin aging.
Innovation Solution
Administration of pharmaceutical compositions comprising mesenchymal stem cells (MSCs) and their exosomes, including dedifferentiated or differentiated MSCs, to inhibit aging and treat aging-associated diseases by reducing fibrosis, inflammation, and improving muscle mass, cognitive function, and glucose homeostasis, among other effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If MSCs are used to treat aging-related disorders, then therapeutic effects are improved, but immunogenicity concerns arise
Solution Approach 1:
The patent extracts and isolates exosomes from mesenchymal stem cells, separating the therapeutic components from the immunogenic cellular elements. This allows the beneficial trophic factors and bioactive molecules to be administered without the immunogenicity concerns associated with whole cell transplantation.
Solution Approach 2:
Exosomes serve as intermediary carriers that deliver therapeutic cargo (proteins, lipids, nucleic acids) from MSCs to target tissues without requiring direct cell contact or transplantation. This intermediary approach maintains therapeutic benefits while avoiding immune rejection issues.
2Ease of operation
If current treatments are used for aging-related disorders, then treatment is simple, but effectiveness across multiple organs is limited
Solution Approach 1:
The patent employs MSC-derived exosomes that exhibit multi-functional therapeutic effects across diverse organ systems. A single treatment approach can simultaneously address aging-related issues in muscle, skin, nervous system, and other tissues due to the broad tropism and immunomodulatory properties of exosomes.
Data Source
AI summary
Methods of treating an aging-associated disease, as well as inhibiting aging in a subject, by administering pharmaceutical compositions comprising unmodified and modified MSCs and their exosomes are provided.